Loading: 100%
FONAR CORP logo
no logo available
General Information
Investor relations pageIR page no data available
Founding year no data available
Headquarter , , no data available
Employees (as per )no data available
Sector Medical Devices, HealthcareMedical Devices, Healthcareno data available
Ticker FONRno data available
Financial year endsFY ends End of Juneno data available
Stock Information (historical prices adjusted for splits and dividends)
Adj. Closing prices (in USD) -Common Shares, Class ANov. 16Jan. 17März 17Mai 17Juli 17Sep. 171520253035
datesClosing price (adj.)
13.10.201731.45
11.10.201730.95
04.10.201730.95
27.09.201730.75
20.09.201729.25
13.09.201728.35
06.09.201729.50
30.08.201729.55
23.08.201727.10
16.08.201726.50
09.08.201726.75
02.08.201726.55
26.07.201728.25
19.07.201729.80
12.07.201728.50
05.07.201727.90
27.06.201727.85
20.06.201728.50
13.06.201727.75
06.06.201727.40
30.05.201724.35
23.05.201723.95
16.05.201722.80
09.05.201719.40
02.05.201719.35
25.04.201719.20
18.04.201718.50
11.04.201718.05
04.04.201717.45
28.03.201718.20
21.03.201718.02
14.03.201718.10
07.03.201718.10
28.02.201718.50
21.02.201718.80
14.02.201718.90
07.02.201718.60
31.01.201718.90
24.01.201719.30
17.01.201720.25
10.01.201720.30
03.01.201719.23
27.12.201619.45
19.12.201619.80
12.12.201620.40
05.12.201619.10
28.11.201620.20
21.11.201620.30
14.11.201619.00
07.11.201616.60
31.10.201618.15
24.10.201619.55
17.10.201619.36
no share price data source found
Share price data requested
Key Figures
Last Closing Price
as per Oct 13, 2017, in USD
31.45n/a
Market Capitalisation
in million USD
198n/a
Enterprise Value
in million USD
197n/a
Common Shares Outstanding
as per Sep 14, 2017
6,287,511n/a
Preferred Shares Outstanding
as per Sep 14, 2017
313,451n/a
Average Basic Shares Outstanding
TTM
6,161,599n/a
Average Diluted Shares Outstanding
TTM
382,513n/a
Index Membership
n/a
Business Summary
Fonar Corp is engaged in the research, development, production and marketing of medical scanning equipment. The Company operates in two segments manufacturing and servicing of medical equipment and management of diagnostic imaging centers.
no data available
Key Financials & Ratios (all figures TTM as per Jun 30, 2017, million USD, full statements further below)
Profit & Loss
Revenues 78n/a
Gross Profit 40n/a
Operating Income 19n/a
EBITDA 0n/a
Net Profit 20n/a
Balance Sheet
Cash and Cash Equivalents 8n/a
Receivables 4n/a
Total Current Assets 51n/a
PP&E 15n/a
Total Assets 184n/a
Accounts Payable 1n/a
Current Debt 1n/a
Total Current Liabilities 14n/a
Long-Term Debt 0n/a
Total Liabilities 16n/a
Total Equity 75n/a
Cash Flow
Depreciation & Amortisation 0n/a
Change in Working Capital 0n/a
Operating Cash Flow 0n/a
Net Change in PP&E and Intangibles 0n/a
Investing Cash Flow 0n/a
Dividends Paid 0n/a
Financing Cash Flow 0n/a
Total Change in Cash 0n/a
Free Cash Flow 0n/a
Profitability Ratios
Gross Margin 51.2%n/a
Operating Margin 24.5%n/a
Net Profit Margin 30.3%n/a
Return on Equity 0.0%n/a
Return on Assets 0.0%n/a
Per Share Figures
Basic EPS 3.18n/a
Diluted EPS 51.29n/a
Sales per Share 12.67n/a
Book Value per Share n/a
FCF per Share n/a
Dividends per Share n/a
Price Multiples
Price to Earnings Ratio 9.88n/a
Price to Sales Ratio 2.48n/a
Price to Book Value n/a
Price to Free Cash Flow n/a
Valuation Metrics
EV/EBITDA n/a
EV/Sales n/a
Book to Market Value 0.38n/a
Other Ratios
Current Ratio 351.8%n/a
Liabilities to Equity Ratio 21.7%n/a
Debt to Assets Ratio 0.6%n/a
Profit & Loss StatementP&L data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '11FY '12FY '13FY '14FY '15FY '16FY '17
Revenue
33
39
49
69
69
73
78
Sales & Services Revenue
0
0
0
0
0
0
0
Financing Revenue
0
0
0
0
0
0
0
Other Revenue
0
0
0
0
0
0
0
Cost of revenue
-18
-21
-26
-36
-37
-39
-38
Cost of Goods & Services
0
0
0
0
0
0
0
Cost of Financing Revenue
0
0
0
0
0
0
0
Cost of Other Revenue
0
0
0
0
0
0
0
Gross Profit
15
18
23
33
32
34
40
Other Operating Income
0
0
0
0
0
0
0
Operating Expenses
-11
-11
-15
-20
-19
-20
-21
Selling, General & Administrative
-8
-9
-13
-19
-17
-19
-19
Selling & Marketing
0
0
0
0
0
0
0
General & Administrative
0
0
0
0
0
0
0
Research & Development
-1
-1
-1
-2
-2
-2
-1
Depreciation & Amortization
0
0
0
0
0
0
0
Provision For Doubtful Accounts
-1
-1
-2
0
0
0
0
Other Operating Expense
0
0
0
0
0
0
0
Operating Income (Loss)
4
7
8
12
13
14
19
Non-Operating Income (Loss)
0
0
0
-1
0
0
0
Interest Expense, net
-1
0
-1
-1
-1
0
0
Interest Expense
0
0
0
0
0
0
0
Interest Income
0
0
0
0
0
0
0
Other Investment Income (Loss)
0
0
0
0
0
0
0
Foreign Exchange Gain (Loss)
0
0
0
0
0
0
0
Income (Loss) from Affiliates
0
0
0
0
0
0
0
Other Non-Operating Income (Loss)
0
0
1
-1
0
0
0
Pretax Income (Loss), Adjusted
3
7
8
11
13
15
19
Abnormal Gains (Losses)
0
0
0
0
0
0
0
Acquired In-Process R&D
0
0
0
0
0
0
0
Merger / Acquisition Expense
0
0
0
0
0
0
0
Abnormal Derivatives
0
0
0
0
0
0
0
Disposal of Assets
0
0
0
0
0
0
0
Early extinguishment of Debt
0
0
0
0
0
0
0
Asset Write-Down
0
0
0
0
0
0
0
Impairment of Goodwill & Intangibles
0
0
0
0
0
0
0
Sale of Business
0
0
0
0
0
0
0
Legal Settlement
0
0
0
0
0
0
0
Restructuring Charges
0
0
0
0
0
0
0
Sale of and Unrealized Investments
0
0
0
0
0
0
0
Insurance Settlement
0
0
0
0
0
0
0
Other Abnormal Items
0
0
0
0
0
0
0
Pretax Income (Loss)
3
7
8
11
13
15
19
Income Tax (Expense) Benefit, net
0
0
2
2
3
4
4
Current Income Tax
0
0
0
0
0
0
0
Deferred Income Tax
0
0
0
0
0
0
0
Tax Allowance/Credit
0
0
0
0
0
0
0
Income (Loss) from Affiliates, net of taxes
0
0
0
0
0
0
0
Income (Loss) from Continuing Operations
3
7
10
13
15
19
24
Net Extraordinary Gains (Losses)
0
0
0
0
0
0
0
Discontinued Operations
0
0
0
0
0
0
0
XO & Accounting Charges & Other
0
0
0
0
0
0
0
Income (Loss) Including Minority Interest
3
7
10
13
15
19
24
Minority Interest
0
-1
-2
-3
-3
-3
-4
Net Income
3
6
9
10
13
16
20
Preferred Dividends
0
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
0
Net Income Available to Common Shareholders
3
6
9
10
13
16
20
Remarks
restated on Oct 26, 2012 n/a
calculated values,
restated on Oct 15, 2013 n/a
calculated values,
restated on Sep 29, 2015 n/a
calculated values,
restated on Sep 28, 2016 n/a
calculated values,
restated on Sep 27, 2017 n/a
calculated values,
restated on Sep 27, 2017 n/a
calculated values,
restated on Sep 27, 2017 n/a
calculated values,
Balance SheetBS data quality: 87% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '11FY '12FY '13FY '14FY '15FY '16FY '17
Assets
Cash, Cash Equivalents & Short Term Investments
9
12
8
10
9
9
10
Cash & Cash Equivalents
9
12
8
10
9
9
10
Short Term Investments
0
0
0
0
0
0
0
Accounts & Notes Receivable
5
0
4
4
4
4
4
Accounts Receivable, Net
5
0
4
4
4
4
4
Notes Receivable, Net
0
0
0
0
0
0
0
Unbilled Revenues
0
0
0
0
0
0
0
Inventories
2
2
2
2
2
2
2
Raw Materials
0
0
0
0
0
0
0
Work In Process
0
0
0
0
0
0
0
Finished Goods
0
0
0
0
0
0
0
Other Inventory
0
0
0
0
0
0
0
Other Short Term Assets
6
1
23
26
28
31
37
Prepaid Expenses
0
0
1
1
1
1
1
Derivative & Hedging Assets
0
0
0
0
0
0
0
Assets Held-for-Sale
0
0
0
0
0
0
0
Deferred Tax Assets
0
0
0
0
0
0
0
Income Taxes Receivable
0
0
0
0
0
0
0
Discontinued Operations
0
0
0
0
0
0
0
Miscellaneous Short Term Assets
5
1
22
25
27
30
36
Total Current Assets
23
16
38
43
44
46
53
Property, Plant & Equipment, Net
4
3
18
15
13
15
16
Property, Plant & Equipment
0
0
0
0
0
0
0
Accumulated Depreciation
0
0
0
0
0
0
0
Long Term Investments & Receivables
0
0
0
0
0
0
0
Long Term Investments
0
0
0
0
0
0
0
Long Term Marketable Securities
0
0
0
0
0
0
0
Long Term Receivables
0
0
0
0
0
0
0
Other Long Term Assets
36
38
91
96
96
110
128
Intangible Assets
0
0
0
0
0
0
0
Goodwill
0
0
2
2
2
3
4
Other Intangible Assets
4
4
12
11
9
8
7
Prepaid Expense
0
0
0
0
0
0
0
Deferred Tax Assets
0
0
3
6
8
13
18
Derivative & Hedging Assets
0
0
0
0
0
0
0
Prepaid Pension Costs
32
34
73
77
76
85
99
Discontinued Operations
0
0
0
0
0
0
0
Investments in Affiliates
0
0
0
0
0
0
0
Miscellaneous Long Term Assets
1
1
1
1
1
1
0
Total Noncurrent Assets
41
41
108
111
109
124
144
Total Assets
63
57
146
154
153
170
198
Liabilities and owners' equity
Payables & Accruals
2 2262115
2 2176846
3 2771980
2 2481997
2 1782442
1 1254485
1 1423217
Accounts Payable
2 2187115
2 2076846
3 2752479
2 2481997
2 1782442
1 1254485
1 1423217
Accrued Taxes
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Interest & Dividends Payable
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Payables & Accruals
0 75000
0 100000
0 19501
0 0
0 0
0 0
0 0
Short Term Debt
2 2025836
2 1853623
3 2885769
3 2890816
2 2490146
2 2447693
0 180090
Short Term Borrowings
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Short Term Capital Leases
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Current Portion of Long Term Debt
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Short Term Liabilities
19 18848338
17 17049139
15 15459863
16 15550278
15 14520064
17 16911069
13 12632696
Deferred Revenue
6 5762394
5 5474614
5 4965415
5 4730962
4 4187401
5 4678914
5 4641534
Derivatives & Hedging
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Tax Liabilities
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Discontinued Operations
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Miscellaneous Short Term Liabilities
13 13085944
12 11574525
10 10494448
11 10819316
10 10332663
12 12232155
8 7991162
Total Current Liabilities
23 23136289
21 21079608
21 21117612
21 20923091
19 18792652
21 20613247
14 14236003
Long Term Debt
2 1746286
1 777274
13 12887005
8 8481830
6 5699302
2 2059236
0 336761
Long Term Borrowings
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Long Term Capital Leases
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Long Term Liabilities
1 832285
1 677055
1 1346757
1 1478330
1 1216610
1 1438816
1 1279849
Accrued Liabilities
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Pension Liabilities
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Pensions
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Post-Retirement Benefits
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Compensation
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Revenue
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Tax Liabilities
0 0
0 0
0 461858
1 583990
1 510492
0 481779
0 331527
Derivatives & Hedging
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Discontinued Operations
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Miscellaneous Long Term Liabilities
1 832285
1 677055
1 884899
1 894340
1 706118
1 957037
1 948322
Total Noncurrent Liabilities
3 2578571
1 1454329
14 14233762
10 9960160
7 6915912
3 3498052
2 1616610
Total Liabilities
26 25714860
23 22533937
35 35351374
31 30883251
26 25708564
24 24111299
16 15852613
Preferred Equity
0 31
0 0
0 0
0 0
0 0
0 0
0 0
Share Capital & Additional Paid-In Capital
173 173476659
174 174084007
174 174499020
175 175284437
175 175447586
174 173702335
179 179131780
Common Stock
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Additional Paid in Capital
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Share Capital
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Treasury Stock
-1 -675390
-1 -675390
-1 -675390
-1 -675390
-1 -675390
-1 -675390
-1 -675390
Retained Earnings
-174 -174110439
-168 -168333958
-160 -159655416
-149 -149259286
-136 -136348635
-121 -120624010
-101 -101003389
Other Equity
0 -131484
0 -70813
0 -54820
0 38828
0 -31495
0 -23879
0 -16546
Equity Before Minority Interest
-1 -1440623
5 5003846
14 14113394
25 25388589
38 38392066
52 52379056
77 77436455
Minority Interest
7 7306437
6 6096560
24 23685215
21 20594984
12 12390771
8 8396575
5 5472799
Total Equity
6 5865814
11 11100406
38 37798609
46 45983573
51 50782837
61 60775631
83 82909254
Total Liabilities & Equity
32 31580674
34 33634343
73 73149983
77 76866824
76 76491401
85 84886930
99 98761867
Remarks restated on Oct 26, 2012 n/a restated on Oct 15, 2013 n/a restated on Sep 29, 2014 n/a restated on Sep 29, 2015 n/a restated on Sep 28, 2016 n/a restated on Sep 27, 2017 n/a restated on Sep 27, 2017 n/a
Cash Flow StatementCF data quality: 0% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '11FY '12FY '13FY '14FY '15FY '16FY '17
Net Income/Starting Line
3
7
10
13
15
19
24
Net Income
0
0
0
0
0
0
0
Net Income From Discontinued Operations
0
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
0
Depreciation & Amortization
2
2
2
4
4
3
4
Non-Cash Items
1
1
-1
0
0
-5
-2
Stock-Based Compensation
0
0
0
0
0
0
0
Deferred Income Taxes
0
0
0
0
0
0
0
Other Non-Cash Adjustments
0
0
0
0
0
0
0
Change in Working Capital
-2
-1
-4
-4
-4
-4
-6
(Increase) Decrease in Accounts Receivable
0
0
0
0
0
0
0
(Increase) Decrease in Inventories
0
0
0
0
0
0
0
Increase (Decrease) in Accounts Payable
0
0
0
0
0
0
0
Increase (Decrease) in Other
0
0
0
0
0
0
0
Net Cash From Discontinued Operations (operating)
0
0
0
0
0
0
0
Cash from Operating Activities
5
9
8
14
15
14
19
Change in Fixed Assets & Intangibles
-1
-1
-1
-1
0
-1
-3
Disposition of Fixed Assets & Intangibles
0
0
0
0
0
0
0
Disposition of Fixed Assets
0
0
0
0
0
0
0
Disposition of Intangible Assets
0
0
0
0
0
0
0
Acquisition of Fixed Assets & Intangibles
0
0
0
0
0
0
0
Purchase of Fixed Assets
0
0
0
0
0
0
0
Acquisition of Intangible Assets
0
0
0
0
0
0
0
Other Change in Fixed Assets & Intangibles
0
0
0
0
0
0
0
Net Change in Long Term Investment
0
0
0
0
0
0
0
Decrease in Long Term Investment
0
0
0
0
0
0
0
Increase in Long Term Investment
0
0
0
0
0
0
0
Net Cash From Acquisitions & Divestitures
0
0
0
0
0
0
0
Net Cash from Divestitures
0
0
0
0
0
0
0
Cash for Acqusition of Subsidiaries
0
0
0
0
0
0
0
Cash for Joint Ventures
0
0
0
0
0
0
0
Net Cash from Other Acquisitions
0
0
0
0
0
0
0
Other Investing Activities
0
0
0
0
0
0
0
Net Cash From Discontinued Operations (investing)
0
0
0
0
0
0
0
Cash from Investing Activities
0
-1
-1
-1
0
0
-2
Dividends Paid
0
0
0
0
0
0
0
Cash From (Repayment of) Debt
-1
-1
-27
-5
-3
-8
-5
Cash From (Repayment of) Short Term Debt, net
0
0
0
0
0
0
0
Cash From (Repayment of) Long Term Debt, net
0
0
0
0
0
0
0
Repayments of Long Term Debt
0
0
0
0
0
0
0
Cash From Long Term Debt
0
0
0
0
0
0
0
Cash From (Repurchase of) Equity
0
0
0
0
0
0
0
Increase in Capital Stock
0
0
0
0
0
0
0
Decrease in Capital Stock
0
0
0
0
0
0
0
Other Financing Activities
7
-2
16
-6
-11
-9
-7
Net Cash From Discontinued Operations (financing)
0
0
0
0
0
0
0
Cash from Financing Activities
5
-4
-11
-11
-14
-17
-12
Net Cash Before Disc. Operations and FX
10
5
-4
2
1
-4
4
Change in Cash from Disc. Operations and Other
0
0
0
0
0
0
0
Net Cash Before FX
10
5
-4
2
1
-4
4
Effect of Foreign Exchange Rates
0
0
0
0
0
0
0
Net Changes in Cash
10
5
-4
2
1
-4
4
Remarks
restated on Oct 26, 2012 n/a
calculated values,
restated on Oct 15, 2013 n/a
calculated values,
restated on Sep 29, 2015 n/a
calculated values,
restated on Sep 28, 2016 n/a
calculated values,
restated on Sep 27, 2017 n/a
calculated values,
restated on Sep 27, 2017 n/a
calculated values,
restated on Sep 27, 2017 n/a
calculated values,
Some of the data shown on this page is provided for free by IEX
Sumo